Form 4: CareCloud Director Lawrence Sharnak Reports New RSU Grant and Stock Conversion

CareCloud, Inc. Director Lawrence Steven Sharnak reported the acquisition of 25,000 restricted stock units and the conversion of 7,500 restricted stock units into common stock.

Summary

• Director Lawrence Steven Sharnak acquired 25,000 Restricted Stock Units (RSUs) on July 31, 2025.
• These newly granted RSUs are scheduled to vest in four equal installments on January 31, 2026, July 31, 2026, January 31, 2027, and July 31, 2027.
• On August 1, 2025, 7,500 previously granted Restricted Stock Units converted into common stock upon vesting.
• Following these transactions, Sharnak directly beneficially owns 106,500 shares of common stock and 47,500 Restricted Stock Units.
• The RSUs and common stock were acquired under the Company's Amended and Restated Equity Incentive Plan without payment by the reporting person.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation for a director, including a new grant and vesting of existing units, which is generally positive as it aligns director interests with long-term company performance. There are no negative or unexpected elements.

Positives

• Director Lawrence Steven Sharnak received a new grant of 25,000 Restricted Stock Units, aligning his interests with long-term shareholder value.
• The vesting of 7,500 Restricted Stock Units into common stock demonstrates the ongoing compensation structure for directors.

Future Outlook

The newly granted 25,000 Restricted Stock Units are scheduled to vest in four equal installments through July 31, 2027, indicating a continued long-term incentive for the director.

Industry Context

This filing reflects standard executive and director compensation practices within the healthcare technology sector, where equity-based incentives like Restricted Stock Units are commonly used to align management interests with long-term company performance and shareholder value.

Comparison to Industry Standards

• Equity-based compensation, specifically Restricted Stock Units (RSUs), is a common practice for director compensation in publicly traded companies across various industries, including healthcare technology.
• The vesting schedule over multiple years is typical for long-term incentive plans, similar to those seen in companies like Teladoc Health (TDOC) or Amwell (AMWL), which also utilize equity grants to retain and incentivize key personnel.
• The acquisition of shares at a $0 price upon vesting of RSUs is standard, as RSUs represent a promise to deliver shares upon the satisfaction of vesting conditions, rather than a purchase.

Corporate Governance

Related Party Transactions

• The grant of 25,000 Restricted Stock Units and the conversion of 7,500 Restricted Stock Units to common stock for Director Lawrence Steven Sharnak are considered related-party transactions as they involve compensation from the company to a director. These transactions were conducted under the Company's Amended and Restated Equity Incentive Plan.

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with long-term shareholder value, potentially encouraging decisions that benefit stock performance.
• Employees: While not directly impacting employees, the use of an equity incentive plan for directors suggests a broader framework for performance-based compensation that may extend to other key personnel.

Next Steps

• Future vesting of 25,000 Restricted Stock Units in four equal installments on January 31, 2026, July 31, 2026, January 31, 2027, and July 31, 2027.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to director compensation, specifically the grant and vesting of Restricted Stock Units. Such filings typically do not contain information that would fundamentally alter the investment thesis for a company. The transactions are expected and reflect standard corporate governance and compensation practices, thus not warranting a change in investment recommendation based solely on this filing.

Keywords

CareCloud, CCLD, Form 4, SEC Filing, Insider Trading, Director Compensation, Restricted Stock Units, Equity Incentive Plan, Stock Ownership